MINIPRESS PFIZER 437 Pill - pink & white capsule/oblong, 18mm
Generic Name: prazosin
Pill with imprint MINIPRESS PFIZER 437 is Pink & White, Capsule/Oblong and has been identified as Minipress 2 mg. It is supplied by Pfizer U.S. Pharmaceuticals Group.
Minipress is used in the treatment of Benign Prostatic Hyperplasia; Heart Failure; High Blood Pressure; Raynaud's Syndrome and belongs to the drug class antiadrenergic agents, peripherally acting. Risk cannot be ruled out during pregnancy. Minipress 2 mg is not a controlled substance under the Controlled Substances Act (CSA).
Images for MINIPRESS PFIZER 437
Minipress
- Generic Name
- prazosin
- Imprint
- MINIPRESS PFIZER 437
- Strength
- 2 mg
- Color
- Pink & White
- Size
- 18.00 mm
- Shape
- Capsule/Oblong
- Availability
- Prescription only
- Drug Class
- Antiadrenergic agents, peripherally acting
- Pregnancy Category
- C - Risk cannot be ruled out
- CSA Schedule
- Not a controlled drug
- Labeler / Supplier
- Pfizer U.S. Pharmaceuticals Group
- Inactive Ingredients
-
FD&C Blue No. 1,
FD&C Red No. 3,
D&C Red No. 28,
FD&C Red No. 40,
magnesium stearate,
sodium lauryl sulfate,
sucrose
Note: Inactive ingredients may vary.
Labelers / Repackagers
| NDC Code | Labeler / Repackager |
|---|---|
| 00069-4370 (Discontinued) | Pfizer Inc. |
| 59762-5320 | Viatris |
| 54868-1290 (Discontinued) | Physicians Total Care Inc. (repackager) |
Related images for "MINIPRESS PFIZER 437"
More about Minipress (prazosin)
- Check interactions
- Compare alternatives
- Reviews (14)
- Drug images
- Side effects
- Dosage information
- During pregnancy
- Generic availability
- Drug class: antiadrenergic agents, peripherally acting
- Breastfeeding
Patient resources
Professional resources
Related treatment guides
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.